In contrast to prior investigations, our study offers a comprehensive analysis of the in vivo function and mechanism of TSP50, highlighting that TSP50 deficiency‐mediated dysfunction of the intestinal mucosal barrier and worsened colitis can be mitigated through the inhibition of TGF‐β signaling. Here, TGFB1 is linked to colitis.